1. HPV-mediated Cervical Cancer: A Systematic Review on Immunological Basis, Molecular Biology, and Immune Evasion Mechanisms
   Kumpati Premkumar et al, 2022, Current Drug Targets CrossRef
2. Cancer in Kenya: types and infection-attributable. Data from the adult population of two National referral hospitals (2008-2012)
   Lucy Wanjiku Macharia et al, 2019, AAS Open Research CrossRef
3. Transcriptomic Analysis of Hub Genes Reveals Associated Inflammatory Pathways in Estrogen-Dependent Gynecological Diseases
   Elaine C. Pasamba et al, 2024, Biology CrossRef
4. Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review)
   JOSÉ VERÍSSIMO FERNANDES et al, 2015, Oncology Letters CrossRef
5. NF-κB1 Intronic Region Polymorphisms as Risk Factor for Head and Neck Cancer in HPV-Infected Population from Pakistan
   Sumaira Sarwar et al, 2022, Current Molecular Medicine CrossRef
6. Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis
   Tynisha S. Rafael et al, 2022, Journal of Clinical Medicine CrossRef
7. Immune evasion mechanisms of human papillomavirus: An update
   Alina Steinbach et al, 2018, International Journal of Cancer CrossRef
8. Penile cancer after a tick bite: A possible association
   Ognen Ivanovski et al, 2021, SAGE Open Medical Case Reports CrossRef
9. Cancer in Kenya: types and infection-attributable. Data from two National referral hospitals
   Lucy Wanjiku Macharia et al, 2019, AAS Open Research CrossRef
10. Burden of cancer in Kenya: types, infection-attributable and trends. A national referral hospital retrospective survey
    Lucy Wanjiku Macharia et al, 2018, AAS Open Research CrossRef
11. Immunology of HPV-mediated cervical cancer: current understanding
    Babban Jee et al, 2021, International Reviews of Immunology CrossRef
12. Functions and modulation of PKM2 activity by human papillomavirus E7 oncoprotein (Review)
    Chengzhi Gui et al, 2022, Oncology Letters CrossRef
13. Cancer in Kenya: types and infection-attributable. Data from the adult population of two National referral hospitals (2008-2012)
    Lucy Wanjiku Macharia et al, 2019, AAS Open Research CrossRef
14. Structure-Based Discovery of Potential HPV E6 and EBNA1 Inhibitors: Implications for Cervical Cancer Treatment
    Emmanuel Broni et al, 2024, Computation CrossRef
15. Efficacy and safety of combined high-dose interferon and red light therapy for the treatment of human papillomavirus and associated vaginitis and cervicitis
    Hui-Juan Shi et al, 2018, Medicine CrossRef
16. Association of human papillomavirus infection and inflammation in cervical cancer
    Nima Hemmat et al, 2019, Pathogens and Disease CrossRef
17. The Interplay between Antiviral Signalling and Carcinogenesis in Human Papillomavirus Infections
    Ana Rita Ferreira et al, 2020, Cancers CrossRef
18. High-sensitivity C-reactive Protein and Regression of Low-grade Squamous Intraepithelial Lesion: The Role of Low-grade Inflammation in Cervical Carcinogenesis
    Sangjeong Ahn et al, 2021, Journal of Epidemiology CrossRef
19. Human papillomavirus, tobacco, and poor oral hygiene can act synergetically, modulate the expression of the nuclear factor kappa B signaling pathway for the development and progression of head and neck cancer in the Pakistani population
    Sumaira Sarwar et al, 2022, Chinese Medical Journal CrossRef